| CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ... Nature medicine 27 (8), 1419-1431, 2021 | 347 | 2021 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 242 | 2017 |
| Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients LS Muffly, M Kocherginsky, W Stock, Q Chu, MR Bishop, LA Godley, ... Haematologica 99 (8), 1373, 2014 | 240 | 2014 |
| Cost effectiveness of chimeric antigen receptor T-cell therapy in multiply relapsed or refractory adult large B-cell lymphoma JK Lin, LS Muffly, MA Spinner, JI Barnes, DK Owens, ... Journal of Clinical Oncology, 2105-2119, 2019 | 193 | 2019 |
| Secondary solid cancer screening following hematopoietic cell transplantation Y Inamoto, NN Shah, BN Savani, BE Shaw, AA Abraham, IA Ahmed, ... Bone marrow transplantation 50 (8), 1013-1023, 2015 | 165 | 2015 |
| Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy JS Abramson, T Feldman, AR Kroll-Desrosiers, LS Muffly, E Winer, ... Annals of oncology 25 (11), 2211-2217, 2014 | 156 | 2014 |
| Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome–negative acute lymphoblastic leukemia: a review SE Siegel, W Stock, RH Johnson, A Advani, L Muffly, D Douer, D Reed, ... JAMA oncology 4 (5), 725-734, 2018 | 138 | 2018 |
| Microwave imaging for neoadjuvant chemotherapy monitoring: Initial clinical experience PM Meaney, PA Kaufman, LS Muffly, M Click, SP Poplack, WA Wells, ... Breast cancer research 15, 1-16, 2013 | 136 | 2013 |
| Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes S Jiang, BW Pogue, CM Carpenter, SP Poplack, WA Wells, CA Kogel, ... Radiology 252 (2), 551-560, 2009 | 133 | 2009 |
| Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients LS Muffly, M Boulukos, K Swanson, M Kocherginsky, P Del Cerro, ... Biology of Blood and Marrow Transplantation 19 (3), 429-434, 2013 | 119 | 2013 |
| Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma JH Baird, DJ Epstein, JS Tamaresis, Z Ehlinger, JY Spiegel, J Craig, ... Blood advances 5 (1), 143-155, 2021 | 112 | 2021 |
| Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, ... Nature Medicine 28 (9), 1860-1871, 2022 | 98 | 2022 |
| Randomized phase III BMT CTN trial of calcineurin inhibitor–free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for … L Luznik, MC Pasquini, B Logan, RJ Soiffer, J Wu, SM Devine, N Geller, ... Journal of Clinical Oncology 40 (4), 356, 2022 | 93 | 2022 |
| Psychological morbidities in adolescent and young adult blood cancer patients during curative‐intent therapy and early survivorship LS Muffly, FJ Hlubocky, N Khan, K Wroblewski, K Breitenbach, J Gomez, ... Cancer 122 (6), 954-961, 2016 | 91 | 2016 |
| Phase I experience with a bi-specific CAR targeting CD19 and CD22 in adults with B-cell malignancies N Hossain, B Sahaf, M Abramian, JY Spiegel, K Kong, S Kim, ... Blood 132, 490, 2018 | 68 | 2018 |
| Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study L Muffly, E Alvarez, D Lichtensztajn, R Abrahão, SL Gomez, T Keegan Blood advances 2 (8), 895-903, 2018 | 67 | 2018 |
| CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma JH Baird, MJ Frank, J Craig, S Patel, JY Spiegel, B Sahaf, JS Oak, ... Blood, The Journal of the American Society of Hematology 137 (17), 2321-2325, 2021 | 63 | 2021 |
| Phase 1 study of CD19/CD22 bispecific chimeric antigen receptor (CAR) therapy in children and young adults with B cell acute lymphoblastic leukemia (ALL) LM Schultz, KL Davis, C Baggott, C Chaudry, AC Marcy, S Mavroukakis, ... Blood 132, 898, 2018 | 58 | 2018 |
| Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients EH Meyer, G Laport, BJ Xie, K MacDonald, K Heydari, B Sahaf, SW Tang, ... JCI insight 4 (10), 2019 | 57 | 2019 |
| Inotuzumab ozogamicin: A CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia IR Yurkiewicz, L Muffly, M Liedtke Drug design, development and therapy, 2293-2300, 2018 | 54 | 2018 |
